Literature DB >> 21364861

A review of clinical data for currently approved hysteroscopic sterilization procedures.

Cindy M Basinski1.   

Abstract

TWO HYSTEROSCOPIC PERMANENT STERILIZATION PROCEDURES ARE APPROVED FOR USE IN THE UNITED STATES: Essure® Permanent Birth Control System (Conceptus Incorporated, Mountain View, CA) and Adiana® Permanent Contraception (Hologic, Inc., Bedford, MA). This review compares the clinical trial data for these procedures. A notable difference is the resultant clinical pregnancy risk. The clinical trials for the Essure procedure have reported no pregnancies in 643 relying women in the 9 years since initiation of the studies. The clinical trial for the Adiana procedure has reported 12 pregnancies in 570 relying women in nearly 5 years of collected data. Other clinical outcome parameters concerning Essure and Adiana are examined in this review.

Entities:  

Keywords:  Adiana; Essure; Hysteroscopic sterilization; Transcervical sterilization

Year:  2010        PMID: 21364861      PMCID: PMC3046759     

Source DB:  PubMed          Journal:  Rev Obstet Gynecol        ISSN: 1941-2797


  8 in total

1.  ACOG Committee Opinion No. 458: Hysterosalpingography after tubal sterilization.

Authors: 
Journal:  Obstet Gynecol       Date:  2010-06       Impact factor: 7.661

2.  ACOG technology assessment in obstetrics and gynecology, number 4, August 2005: hysteroscopy.

Authors: 
Journal:  Obstet Gynecol       Date:  2005-08       Impact factor: 7.661

Review 3.  Essure: a review six years later.

Authors:  Viviane F Connor
Journal:  J Minim Invasive Gynecol       Date:  2009 May-Jun       Impact factor: 4.137

4.  A 12-month prospective evaluation of transcervical sterilization using implantable polymer matrices.

Authors:  Thierry G Vancaillie; Ted L Anderson; D Alan Johns
Journal:  Obstet Gynecol       Date:  2008-12       Impact factor: 7.661

5.  The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization.

Authors:  H B Peterson; Z Xia; J M Hughes; L S Wilcox; L R Tylor; J Trussell
Journal:  Am J Obstet Gynecol       Date:  1996-04       Impact factor: 8.661

6.  Microinsert nonincisional hysteroscopic sterilization.

Authors:  Jay M Cooper; Charles S Carignan; Daniel Cher; John F Kerin
Journal:  Obstet Gynecol       Date:  2003-07       Impact factor: 7.661

7.  Hysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II study.

Authors:  John F Kerin; Jay M Cooper; Thomas Price; Bruno J Van Herendael; Enrique Cayuela-Font; Daniel Cher; Charles S Carignan
Journal:  Hum Reprod       Date:  2003-06       Impact factor: 6.918

8.  Tissue encapsulation of the proximal Essure micro-insert from the uterine cavity following hysteroscopic sterilization.

Authors:  John F Kerin; David Munday; Martin Ritossa; David Rosen
Journal:  J Minim Invasive Gynecol       Date:  2007 Mar-Apr       Impact factor: 4.137

  8 in total
  3 in total

1.  Global endometrial ablation in the presence of essure® microinserts.

Authors:  Diana Aldape; Scott G Chudnoff; Mark D Levie
Journal:  Rev Obstet Gynecol       Date:  2013

2.  Management of long-term and reversible hysteroscopic sterilization: a novel device with nickel-titanium shape memory alloy.

Authors:  Bin Xu; Ke-an Zhu; Dabao Xu; Aixingzi Aili
Journal:  Reprod Biol Endocrinol       Date:  2014-07-07       Impact factor: 5.211

3.  Hysteroscopic sterilization in immunocompromised patients who have intrauterine devices in place: two case reports.

Authors:  Camille Ladanyi; Carlie Field; Kristina Tocce
Journal:  J Med Case Rep       Date:  2015-10-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.